Free tool
FAERS Monitor: Kaletra
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021906 or its brand name (Kaletra, Lopinavir, Ritonavir). Reports on generic versions are filed under their own applications.
Reports
13,489
Serious
12,415
92% of reports
Hospitalization
5,010
Death reported
1,781
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug interaction1,338
- depression1,141
- nausea791
- drug exposure during pregnancy778
- diarrhoea774
- foetal exposure during pregnancy757
- anxiety712
- vomiting712
- off label use695
- pain692
- emotional distress578
- renal failure540
- pyrexia526
- anhedonia510
- anaemia452
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 761 |
| 2005 | 608 |
| 2006 | 677 |
| 2007 | 725 |
| 2008 | 999 |
| 2009 | 1,056 |
| 2010 | 922 |
| 2011 | 628 |
| 2012 | 681 |
| 2013 | 469 |
| 2014 | 576 |
| 2015 | 587 |
| 2016 | 407 |
| 2017 | 268 |
| 2018 | 312 |
| 2019 | 427 |
| 2020 | 1,446 |
| 2021 | 862 |
| 2022 | 473 |
| 2023 | 217 |
| 2024 | 137 |
| 2025 | 177 |
| 2026 | 69 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,670 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug exposure during pregnancySignal | 778 | 36.5 | 34.1 | 26,245 |
| anhedoniaSignal | 510 | 30.8 | 28.3 | 14,427 |
| foetal exposure during pregnancySignal | 757 | 14.6 | 13.7 | 9,560 |
| drug interactionSignal | 1,338 | 13.3 | 12.6 | 15,133 |
| depressionSignal | 1,141 | 7.9 | 7.4 | 6,857 |
| emotional distressSignal | 578 | 7.5 | 6.9 | 3,239 |
| renal failureSignal | 540 | 6.4 | 5.9 | 2,441 |
| anxietySignal | 712 | 3.9 | 3.6 | 1,555 |
| anaemiaSignal | 452 | 3.7 | 3.4 | 895 |
| pyrexiaSignal | 526 | 2.4 | 2.2 | 423 |
| vomitingSignal | 712 | 2.4 | 2.2 | 571 |
| diarrhoea | 774 | 1.9 | 1.7 | 322 |
| pain | 692 | 1.8 | 1.6 | 232 |
| nausea | 791 | 1.6 | 1.5 | 164 |
| off label use | 695 | 1.2 | 1.2 | 33 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.